Adaptimmune Therapeutics has started its SPEARHEAD-1 trial with ADP-A2M4 SPEAR T-cells for patients with synovial sarcoma or myxoid/round cell liposarcoma. Earlier this year, Adaptimmune presented compelling data with responses observed in synovial sarcoma patients treated in the ADP-A2M4 pilot study.
The ATG-010 is a first-in-class selective inhibitor of nuclear export (SINE) compound in late clinical development to treat multiple haematological malignancies and solid tumours such as multiple myeloma, diffuse large B-cell lymphoma and liposarcoma. ATG-008 is a second generation TORC1/2 inhibitor, which is currently in development to treat hepatitis B virus positive (HBV+) hepatocellular carcinoma.
Its ATG-010 (selinexor) is a first-in-class Selective Inhibitor of Nuclear Export (SINE) compound in late clinical development for the treatment of multiple hematological malignancies and solid tumours, including multiple myeloma, diffuse large B-cell lymphoma and liposarcoma.
Dedifferentiated liposarcoma is the most heterogeneous of all sarcomas with a wide variety of histologic patterns including tumors with distinctive patterns, tumors with heterologous and homologous differentiation, and lowgrade tumors.
Computer tomography revealed a giant pelvic mass which lead to left side hydronephrosis, hydrouterer and a pear-shaped bladder, with the differential diagnosis including pelvic lipoma or liposarcoma. An ultrasound guided biopsy excluded the diagnosis of liposarcoma.
Dedifferentiated liposarcoma arising in the background of well-differentiated liposarcoma, with MDM2 gene amplification detected on fluorescent in-situ hybridization (FISH) testing.
Rarely, a lump that appears to be a benign lipoma may be a type of cancer called a liposarcoma; that's why it is important to undergo testing, such as an MRI or CT scan and/or a biopsy, to confirm that the lump is noncancerous.
Atypical lipomatous tumor (ALT) and well-differentiated liposarcoma (WDL) are rare liposarcoma subtypes that are histologically identical but distinguished by the 2002 WHO classification: ALTs occur in surgically amenable locations, whereas WDLs do not.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.